NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease

類似資料

• Discovery of neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway
  著者:: Siklos, Marton I, 等
  出版事項: (2013)
• Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery
  著者:: Hollas, Michael A., 等
  出版事項: (2018)
• An NO Donor Approach to Neuroprotective and Procognitive Estrogen Therapy Overcomes Loss of NO Synthase Function and Potentially Thrombotic Risk
  著者:: VandeVrede, Lawren, 等
  出版事項: (2013)
• Transgenic Mice for cGMP Imaging
  著者:: Thunemann, Martin, 等
  出版事項: (2013)
• Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
  著者:: Wen, Lai, 等
  出版事項: (2013)